Basic Information
RNALocate ID: RLID:11001503
RNA Symbol: hsa-miR-181a-3p
Localization: Exosome
RNA Information
RNA Name: hsa-miR-181a-3p
RNA ID: miRBase:MIMAT0000270
RNA Category: miRNA
Species: Homo sapiens
Sequence:
Localization Information
PubMed ID: 23663360
Tissue/Cell Line: Plasma
Method: Next-generation RNA sequencing
Description: Because the abundance of most miRNAs is low in the exosomes, we defined detectable miRNAs as those that had at least one sequence per million mappable miRNA reads. Accordingly, we detected a total of 593 known miRNAs in the 14 libraries. In each individual library, the number of detectable known miRNAs varied from 380 to 474 with an average of 419 [see Additional file 2]. Data are collected from Additional file 2: Read counts of the miRNAs detected in the 14 libraries (normalized to read number per million mappable miRNA seqeuences).
Other Subcellular Localization
RNALocate ID Localization Tissue/Cell line PubMed ID
RLID:01001657 Mitochondrion Skeletal muscle myoblasts 21637849
RLID:11001501 Exosome Jurkat-derived T cell line (J77cl20) 21505438
RLID:11001502 Exosome Brain tissue 23382797
RLID:11001504 Microvesicle Cerebrospinal fluid 24797360
RLID-D:11000059 Exosome B lymphoblastoid cells|Endothelial cells|Lymphoma tissue
RLID-D:11000331 Microvesicle Fibroblasts|Mesenchymal stem cells
ncRNA Disease Information
Resource RNA Symbol Disease Link
MNDR hsa-miR-181a-3p Multiple sclerosis chronic progressive MNDR-E-MI-19434
MNDR hsa-miR-181a-3p Oral squamous cell carcinoma MNDR-E-MI-19435
MNDR hsa-miR-181a-3p Large cell neuroendocrine cancer MNDR-E-MI-19436
MNDR hsa-miR-181a-3p Follicular lymphoma MNDR-E-MI-19437
MNDR hsa-miR-181a-3p Lymphoma MNDR-E-MI-19438
MNDR hsa-miR-181a-3p Estrogen-receptor positive breast cancer MNDR-E-MI-19439
MNDR hsa-miR-181a-3p Estrogen-receptor negative breast cancer MNDR-E-MI-19440
MNDR hsa-miR-181a-3p Progesterone-receptor positive breast cancer MNDR-E-MI-19441
MNDR hsa-miR-181a-3p Progesterone-receptor negative breast cancer MNDR-E-MI-19442
MNDR hsa-miR-181a-3p Her2-receptor positive breast cancer MNDR-E-MI-19443
MNDR hsa-miR-181a-3p Breast cancer luminal MNDR-E-MI-19444
MNDR hsa-miR-181a-3p Precursor cell lymphoblastic leukemia-lymphoma MNDR-E-MI-19445
MNDR hsa-miR-181a-3p Prostate cancer MNDR-E-MI-19446
MNDR hsa-miR-181a-3p Chronic lymphocytic leukemia MNDR-E-MI-19447
MNDR hsa-miR-181a-3p Gastric cancer MNDR-E-MI-19448
MNDR hsa-miR-181a-3p Gastric lymphoma MNDR-E-MI-19449
MNDR hsa-miR-181a-3p Alzheimer disease MNDR-E-MI-19450
MNDR hsa-miR-181a-3p Esophageal carcinoma MNDR-E-MI-19451
MNDR hsa-miR-181a-3p Leukemia MNDR-E-MI-19452
MNDR hsa-miR-181a-3p Huntington disease MNDR-E-MI-19453
MNDR hsa-miR-181a-3p Chorea MNDR-E-MI-19454
MNDR hsa-miR-181a-3p Cardiovascular disease MNDR-E-MI-19455
MNDR hsa-miR-181a-3p Lung cancer MNDR-E-MI-19456
MNDR hsa-miR-181a-3p Down syndrome MNDR-E-MI-19457
MNDR hsa-miR-181a-3p Parkinson disease MNDR-E-MI-19458
MNDR hsa-miR-181a-3p Basal-like breast cancer MNDR-E-MI-19459
MNDR hsa-miR-181a-3p Pancreatic cancer MNDR-E-MI-19460
MNDR hsa-miR-181a-3p Melanoma MNDR-E-MI-19461
MNDR hsa-miR-181a-3p Rectum adenocarcinoma MNDR-E-MI-19462
MNDR hsa-miR-181a-3p Colon cancer MNDR-E-MI-19463
MNDR hsa-miR-181a-3p Multiple sclerosis relapsing-remitting MNDR-E-MI-19464
MNDR hsa-miR-181a-3p Familial ovarian cancer MNDR-E-MI-19465
MNDR hsa-miR-181a-3p Prostate adenocarcinoma MNDR-E-MI-19466
MNDR hsa-miR-181a-3p Carcinoma ductal breast MNDR-E-MI-19467
MNDR hsa-miR-181a-3p Glioma MNDR-E-MI-19468
MNDR hsa-miR-181a-3p Osteosarcoma MNDR-E-MI-19469
MNDR hsa-miR-181a-3p Breast carcinoma MNDR-E-MI-19470
MNDR hsa-miR-181a-3p Uterine cancer MNDR-E-MI-19471
MNDR hsa-miR-181a-3p Gastric adenocarcinoma MNDR-E-MI-19472
MNDR hsa-miR-181a-3p Lung squamous cell carcinoma MNDR-E-MI-19473
MNDR hsa-miR-181a-3p Lung adenocarcinoma MNDR-E-MI-19474
MNDR hsa-miR-181a-3p Thyroid carcinoma MNDR-E-MI-19475
MNDR hsa-miR-181a-3p Papillary thyroid carcinoma MNDR-E-MI-19476
MNDR hsa-miR-181a-3p Bladder urothelial carcinoma MNDR-E-MI-19477
MNDR hsa-miR-181a-3p Pancreatic adenocarcinoma MNDR-E-MI-19478
MNDR hsa-miR-181a-3p Carcinoma renal cell MNDR-E-MI-19479
MNDR hsa-miR-181a-3p Kidney renal papillary cell carcinoma MNDR-E-MI-19480
MNDR hsa-miR-181a-3p Clear cell renal cell carcinoma MNDR-E-MI-19481
MNDR hsa-miR-181a-3p Esophageal cancer MNDR-E-MI-19482
MNDR hsa-miR-181a-3p Lung small cell carcinoma MNDR-E-MI-19483
MNDR hsa-miR-181a-3p Synovial sarcoma MNDR-E-MI-19484
MNDR hsa-miR-181a-3p Stomach carcinoma MNDR-E-MI-19485
MNDR hsa-miR-181a-3p Head and neck squamous cell carcinoma MNDR-E-MI-19486
MNDR hsa-miR-181a-3p Acute t cell leukemia MNDR-E-MI-19487
MNDR hsa-miR-181a-3p Breast invasive carcinoma MNDR-E-MI-19488
MNDR hsa-miR-181a-3p Hepatocellular carcinoma MNDR-E-MI-19489
MNDR hsa-miR-181a-3p Familiar ovarian carcinoma MNDR-E-MI-19490
MNDR hsa-miR-181a-3p Rheumatoid arthritis MNDR-E-MI-19491
MNDR hsa-miR-181a-3p Hodgkin lymphoma MNDR-E-MI-19492
MNDR hsa-miR-181a-3p Neuromyelitis optica MNDR-E-MI-19493
MNDR hsa-miR-181a-3p Skin cutaneous melanoma MNDR-E-MI-19494
MNDR hsa-miR-181a-3p Skin melanoma MNDR-E-MI-19495
MNDR hsa-miR-181a-3p Acute myeloid leukemia MNDR-E-MI-19496
MNDR hsa-miR-181a-3p Nasopharynx carcinoma MNDR-E-MI-19497
MNDR hsa-miR-181a-3p Multiple myeloma MNDR-E-MI-19498
MNDR hsa-miR-181a-3p Nasopharyngeal cancer MNDR-E-MI-19499
MNDR hsa-miR-181a-3p Solid-pseudopapillary neoplasm of pancreas MNDR-E-MI-19500
RNA Interaction Information
Resource RNA Symbol Species Link RNALocate ID
RNAInter AFAP1-AS1 Homo sapiens RR00052030
TOP